BiotechTubeBiotechTube
Home/Advanced NanoTherapies/Michael Mandel
MM

Michael Mandel

Head of Corporate Development

Advanced NanoTherapies

Therapeutic Areas

CardiovascularPeripheral Vascular DiseaseCoronary Artery Disease

Advanced NanoTherapies Pipeline

DrugIndicationPhase
SirPlux Duo DCBCoronary Artery Disease (CAD)Pre-clinical
Single-drug DCB Platform (Paclitaxel)Vascular Disease (Proof-of-Concept)Pre-clinical
Single-drug DCB Platform (Sirolimus)Vascular Disease (Proof-of-Concept)Pre-clinical

Leadership Team at Advanced NanoTherapies

MB
Marwan Berrada
Chief Executive Officer
VL
Vinod Labhasetwar
Scientific Advisor
FP
Frank Proch
Vice President, R&D
AM
Angela Mallery
Vice President, Regulatory Affairs & Quality Assurance
JG
Joey Groszek
Director, Nanoparticle R&D
MH
Mike Hogan
Senior Director, Engineering
PM
Paul McFeely
Senior Manager, Quality Assurance
AL
Azeem Latib
Scientific Advisory Board Member
GA
Gary Ansel
Scientific Advisory Board Member
PS
Peter Schneider
Scientific Advisory Board Member
View full Advanced NanoTherapies profile